ABGENIX

Welcome to the Brand page for “ABGENIX”, which is offered here for Pharmaceuticals, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases;biochemicals, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals;animal embryos for laboratory use;pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others;.

Its status is currently believed to be active. Its class is unavailable. “ABGENIX” is believed to be currently owned by “ABGENIX, INC.”